Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J subpoenaed for products sold to Omnicare

Executive Summary

J&J is responding to a subpoena for eight products sold to Omnicare, the company says in its 10-Q filing. The company reported receiving the subpoena from the U.S. Attorney's office in Massachusetts on Sept. 26. In July, J&J received a subpoena related to the sales and marketing of its congestive heart failure drug Natrecor (nesiritide). Omnicare broadened its long-term care pharmacy practice and specialty pharmaceutical distribution through the acquisition of NeighborCare and RxCrossroads in July (1"The Pink Sheet" July 11, 2005, p. 16)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS046557

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel